Joint pain is one of several symptoms that could occur during the early stage of eosinophilia-myalgia syndrome. For many patients, the early phase of the illness can last between three to six months.

Clinical image shows extensive discoloration and woody induration of the patient's right forearm. A 72-year-old woman presented to a rheumatology clinic for evaluation of mild pain and joint ...

Eosinophilia-myalgia syndrome is a rare condition resulting from elevated levels of a type of white blood cell. Symptoms include muscle pain and neurological issues.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Eosinophils are a type of blood cells which helps to fight off certain infections and participates in the body’s immune reactions. Eosinophilia is a condition in which the peripheral blood ...

Eosinophils are specialized white blood cells that curb infection and boost inflammation. If you have too many, it’s called eosinophilia. Learn how EOS blood tests can help diagnose allergic ...

After 3 months of therapy, a significant improvement in gastrointestinal and joint pain symptoms was observed and an upper endoscopy revealed a normal appearance of his esophagus.

Diagnosis of eosinophilic esophagitis is based on clinical history as well as eosinophilic-predominant inflammation on histological examination of biopsies taken at endoscopy. First-line treatment may ...

Your treatment for eosinophilic esophagitis (EoE) typically begins with a prescription acid blocker called a proton pump inhibitor (PPI). If a PPI doesn ’ t work, your doctor may also prescribe ...

A 37-year-old man presented with arthralgias, rash, calf pain, and redness in both eyes. The C-reactive protein level was elevated, and the erythrocyte sedimentation rate was prolonged. Examination ...

Systemic symptoms such as fever, joint pain and swelling, or lymphadenopathy Drug exposure should be classified based on the association between the drug and the chances of eosinophilia.